Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treatment of papulopustular rosacea with Oxofulleram (pilot unilateral application study)
2014-004962-76Phase 2Active
- Sponsor
- Soleno Therapeutics
- Start
- Dec 2014
- Modality
- Small Molecules, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, randomised trial of oxofulleram in papulopustular rosacea (2 arms), sponsored by Soleno Therapeutics. Primary endpoint: Objective left-right difference in papulopustular rosacea severity. Started Dec 2014; status: active.
02
Drugs
oxofulleram
03
Conditions
papulopustular rosacea
Beyond the preview
Go deeper on 2014-004962-76.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004962-76.